VA Will Mandate Informed Consent for Medications in 2027

New guidance will require veteran signatures for certain high-risk psychotropic drug prescriptions by 2027.

Updated on Sept. 29, 2026 in Mental Health

Bold flat-color editorial illustration featuring a minimalist architectural column representing medical policy, rendered in navy blue and cream. — The Department of Veterans Affairs will mandate signature-based informed consent for high-risk psychotropic medication prescriptions for veterans starting in 2027. AI Illustration. Upload story photo >

Live Poll

Do you believe stricter informed consent requirements for psychiatric medications will improve patient care?

The Department of Veterans Affairs will implement new informed consent requirements for psychotropic medications starting in 2027. This policy aims to improve transparency regarding risks and benefits for veterans enrolled in VA healthcare.

Why it matters

The change addresses the high prevalence of psychiatric drug use among veterans, including 80 percent of those diagnosed with PTSD, by ensuring they are better informed about their treatments.

Approximately 4.5 million veterans are currently prescribed psychotropic medications, with 80 percent of those diagnosed with PTSD receiving psychiatric drugs. The VA is also overseeing 20 active clinical trials for psychedelic-assisted therapies.

The players

Department of Veterans Affairs

This federal agency is responsible for providing healthcare services and benefits to eligible military veterans.

President Donald Trump

As the current President of the United States, he issued an executive order in 2026 to expand access to psychedelic research.

The details

The department will mandate signature consent before prescribing antidepressants to veterans younger than 30 or when concurrently prescribing opioids and benzodiazepines. This policy coincides with a broader shift in mental health strategy spurred by a 2026 executive order that provided $50 million via ARPA-H for state-level psychedelic programs.

April 2026: President Trump issued an executive order on psychedelic access.
September 28, 2026: The VA announced the new medication consent guidance.
2027: New informed consent guidance takes effect.

The Big Picture

This story follows a pattern set by the ARPA-H psychedelic funding executive order, which expanded federal focus on alternative mental health treatments.

Veterans under 30 or those prescribed combined opioids and benzodiazepines will face new signature requirements when receiving prescriptions. This change ensures patients have a formal record of discussing potential risks with their VA providers.

The takeaway

The VA is shifting toward a more transparent informed consent model to manage the high usage of psychotropic drugs among its veteran population. Veterans should prepare for these administrative changes at their medical appointments beginning in 2027.

What happens next

The new informed consent guidance is scheduled to take effect in 2027, at which point veterans will be required to sign disclosures before specific psychotropic drug prescriptions are authorized.